Anne Anderson, MD
Dr. Anderson is clinician scientist in the field of pediatric epilepsy. She is Professor in the Departments of Pediatrics, Neurology, and Neurosciences at Baylor College of Medicine. She is an active clinician in pediatric epilepsy and clinical neurophyiology and serves as Medical Director of Clinical Neurophysiology at TCH. She is also a principal investigator in the Gordon and Mary Cain Pediatric Neurology Research Foundation Laboratories at TCH in the Jan and Dan Duncan Neurological Research Institute. Her clinical work in pediatric epilepsy drives the research questions and translational studies. In particular, she sees patients in the outpatient Angelman Syndrome Clinic and also as inpatients and in the research lab is involved in translational studies involving models of Angelman Syndrome.
Scientific Advisory Board • Board Member
Baylor College of Medicine, Texas Children's Hospital | Houston, TX
Notable Publications:
b. Born HA, Martinez LA, Levine AT, Harris SE, Mehra S, Lee WL, Dindot SV, Nash KR, Silverman JL, Segal DJ, Weeber EJ, Anderson AE. Early developmental EEG and seizure phenotypes in a full gene deletion of ubiquitin protein ligase E3A rat model of Angelman syndrome. eNeuro. 2021 Mar-Apr;8(2). PMCID: PMC8114899.
d. Martinez LA, Born HA, Harris S, Regnier-Golanov A, Grieco JC, Weeber EJ, Anderson AE. Quantitative EEG analysis in Angelman syndrome: Candidate method for Assessing therapeutics. Clin EEG Neurosci. 2020 Nov18; Online ahead of print. PMID: 33203220
a. Born HA, Dao AT, Levine AT, Lee WL, Mehta NM, Mehra S, Weeber EJ, Anderson AE. Strain-dependence of the Angelman Syndrome phenotypes in Ube3a maternal deficiency mice. Sci Rep. 2017 Aug 16;7(1):8451. PMCID: PMC5559514.
Contact Dr. Anderson:
Email: annea@bcm.edu